Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction

American Journal of Cardiology

Volumn 95, Issue 5, 2005, Pages 553-557

  Ndrepepa, Gjin ^a   Braun, Siegmund ^b   Mehilli, Julinda ^b   Von Beckerath, Nicolas ^b   Vogt, Wolfgang ^b   Schömig, Albert ^b   Kastrati, Adnan ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; AMINO TERMINAL SEQUENCE; ANGIOCARDIOGRAPHY; ARTICLE; CHI SQUARE TEST; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

EID: 13844296460     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.10.034     Document Type: Article

References (28)

1. S. Wiese, T. Breyer, A. Dragu, R. Wakili, T. Burkard, S. Schmidt-Schweda, E.M. Fuchtbauer, U. Dohrmann, F. Beyersdorf, D. Radicke, C.J. Holubarsch Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length Circulation 102 2000 3074 3079
2. M. Yoshimura, H. Yasue, K. Okumura, H. Ogawa, M. Jougasaki, M. Mukoyama, K. Nakao, H. Imura Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87 1993 464 469
3. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, M. Jougasaki, H. Ogawa, K. Okumura, M. Mukoyama, K. Nakao Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
4. J.A. de Lemos, D.K. McGuire, M.H. Drazner B-type natriuretic peptide in cardiovascular disease Lancet 362 2003 316 322
5. T.G. Yandle, A.M. Richards, A. Gilbert, S. Fisher, S. Holmes, E.A. Espiner Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure J Clin Endocrinol Metab 76 1993 832 838
6. T. Omland, A. Aakvaag, H. Vik-Mo Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment Heart 76 1996 232 237
7. Q. Dao, P. Krishnaswamy, R. Kazanegra, A. Harrison, R. Amirnovin, L. Lenert, P. Clopton, J. Alberto, P. Hlavin, A.S. Maisel Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting J Am Coll Cardiol 37 2001 379 385
8. S. Talwar, I.B. Squire, P.F. Downie, J.E. Davies, L.L. Ng Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina Heart 84 2000 421 424
9. K. Kikuta, H. Yasue, M. Yoshimura, E. Morita, H. Sumida, H. Kato, K. Kugiyama, H. Ogawa, K. Okumura, Y. Ogawa, K. Nakao Increased plasma levels of B-type natriuretic peptide in patients with unstable angina Am Heart J 132 1996 101 107
10. E. Morita, H. Yasue, M. Yoshimura, H. Ogawa, M. Jougasaki, T. Matsumura, M. Mukoyama, K. Nakao Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 88 1993 82 91
11. N. Arakawa, M. Nakamura, H. Aoki, K. Hiramori Relationship between plasma level of brain natriuretic peptide and myocardial infarct size Cardiology 85 1994 334 340
12. T. Omland, V.V. Bonarjee, R.T. Lie, K. Caidahl Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction Am J Cardiol 76 1995 230 235
13. T. Jernberg, M. Stridsberg, P. Venge, B. Lindahl N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation J Am Coll Cardiol 40 2002 437 445
14. S.K. James, B. Lindahl, A. Siegbahn, M. Stridsberg, P. Venge, P. Armstrong, E.S. Barnathan, R. Califf, E.J. Topol, M.L. Simoons, L. Wallentin N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy Circulation 108 2003 275 281
15. T. Jernberg, B. Lindahl, A. Siegbahn, B. Andren, G. Frostfeldt, B. Lagerqvist, M. Stridsberg, P. Venge, L. Wallentin N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease J Am Coll Cardiol 42 2003 1909 1916
16. J.A. de Lemos, D.A. Morrow, J.H. Bentley, T. Omland, M.S. Sabatine, C.H. McCabe, C. Hall, C.P. Cannon, E. Braunwald The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
17. J.D. Rutherford, E. Braunwald, P.F. Cohn Chronic ischemic heart disease E. Braunwald Heart Disease: A Textbook of Cardiovascular Medicine 3rd Ed 1988 WB Saunders Philadelphia 1314 1378
18. World Health Organization Diabetes mellitus WHO Tech Rep Ser 727 1985 1 104
19. L.J. Sokoll, P. Collinson, E. Gurr, M. Haass, I. Morton, W. Nowatzke, C. Zingler Performance evaluation of Elecsys proBNP in a multicenter study Clin Chem Lab Med 42 2004 965 972
20. P.O. Collinson, S.C. Barnes, D.C. Gaze, G. Galasko, A. Lahiri, R. Senior Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys trade mark 1010 and 2010 analysers Eur J Heart Fail 6 2004 365 368
21. K. Marumoto, M. Hamada, K. Hiwada Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris Clin Sci (Lond) 88 1995 551 556
22. J. Tateishi, M. Masutani, M. Ohyanagi, T. Iwasaki Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty Clin Cardiol 23 2000 776 780
23. J. Pan, K. Fukuda, M. Saito, J. Matsuzaki, H. Kodama, M. Sano, T. Takahashi, T. Kato, S. Ogawa Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes Circ Res 84 1999 1127 1136
24. K. Nakao, M. Mukoyama, K. Hosoda, S. Suga, Y. Ogawa, Y. Saito, G. Shirakami, H. Arai, M. Jougasaki, H. Imura Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide Can J Physiol Pharmacol 69 1991 1500 1506
25. N. Hama, H. Itoh, G. Shirakami, O. Nakagawa, S. Suga, Y. Ogawa, I. Masuda, K. Nakanishi, T. Yoshimasa, Y. Hashimoto Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction Circulation 92 1995 1558 1564
26. J.P. Goetze, C. Christoffersen, M. Perko, H. Arendrup, J.F. Rehfeld, J. Kastrup, L.B. Nielsen Increased cardiac BNP expression associated with myocardial ischemia FASEB J 17 2003 1105 1107
27. W.E. Hopkins, Z. Chen, N.K. Fukagawa, C. Hall, H.J. Knot, M.M. LeWinter Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion Circulation 109 2004 2872 2877
28. T. Omland, A. Persson, L. Ng, R. O'Brien, T. Karlsson, J. Herlitz, M. Hartford, K. Caidahl N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918